Attention Deficit Hyperactivity Disorder (ADHD) affects millions of children — but early diagnosis and the right treatment can make a world of difference. In this episode of Hope in the Pipeline, Dr. Paul Wylie, Neuropsychiatry and Sleep Medicine Specialist, explores the symptoms, causes, and treatment options for pediatric ADHD.

We also dive into an exciting new clinical research trial for children ages 4 to 5 years and 7 months, testing a non-controlled medication already approved for older children and adults. This trial could help shape the future of ADHD treatment — and eligible families may receive a formal diagnosis and compensation for participation.

Learn how ADHD presents differently in boys and girls, the role of genetics and sleep, and why your child’s struggles might have a biological solution.

📍 Visit PreferredResearchPartners.com to learn more or apply for the study.

🔔 Don’t forget to like, share, and subscribe for more episodes on mental health breakthroughs.

In this episode of Hope in the Pipeline, Dr. Paul Wylie discusses pediatric migraines, their prevalence, symptoms, and treatment options. He highlights the importance of understanding how migraines affect children differently than adults and the potential for clinical trials to improve treatment outcomes. The conversation emphasizes the need for awareness and research in managing pediatric migraines effectively.

In this episode of Hope in the Pipeline, Dr. Paul Wylie sheds light on narcolepsy—a complex neurological sleep disorder marked by overwhelming daytime sleepiness and sudden muscle weakness known as cataplexy. He breaks down the different types of narcolepsy, explores its symptoms, and dives into the science behind it, from genetic links to autoimmune triggers. The conversation also highlights current treatment options and promising clinical trials that aim to improve the quality of life for those living with this challenging condition.

#narcolepsy #sleepdisorder #clinicaltrials #sleepmedicine